SCHEMBL30108037

SCHEMBL30108037

COc1ccc2c(c1)nnn2-c1cc(Cc2ccco2)nc(SC)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPC5 Q9UL62 1/20 0.37
ALDH1A1 P00352 10/20 0.36
PKM P14618 2/20 0.36
BRD4 O60885 2/20 0.36
HPGD P15428 7/20 0.35
KDM4E B2RXH2 6/20 0.35
HTT P42858 5/20 0.35
TSHR P16473 4/20 0.35
HSD17B10 Q99714 3/20 0.35
GLA P06280 2/20 0.35
GAA P10253 2/20 0.35
MAPK10 P53779 1/20 0.35
CYP19A1 P11511 1/20 0.35
MAPT P10636 4/20 0.35
POLB P06746 3/20 0.35
RAB9A P51151 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
MEN1 O00255 1/20 0.35
THRB P10828 1/20 0.35
ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108039 0.87 ALDH1A1 (0.40) TRPC5ALDH1A1PKMBRD4HPGD
SCHEMBL30107990 0.83 ALDH1A1 (0.37) TRPC5ALDH1A1PKMBRD4HPGD
SCHEMBL30107949 0.79 HTT (0.34) ALDH1A1PKMBRD4HPGDKDM4E
SCHEMBL30107966 0.78 TSHR (0.40) ALDH1A1KDM4EHTTTSHRHSD17B10
SCHEMBL30108047 0.78 RAB9A (0.39) ALDH1A1PKMHPGDKDM4EHSD17B10
SCHEMBL30107974 0.78 MAPT (0.40) ALDH1A1KDM4EHTTTSHRHSD17B10
SCHEMBL30107992 0.71 ADORA2A (0.37) ALDH1A1PKMHPGDKDM4ETSHR
SCHEMBL30107973 0.71 KDM4E (0.46) ALDH1A1HPGDKDM4EHTTTSHR
SCHEMBL30107951 0.69 PTGS1 (0.46) ALDH1A1HPGDKDM4EHTTTSHR
SCHEMBL30107975 0.67 L3MBTL1 (0.40) ALDH1A1KDM4EHTTTSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed